montelukast "accord healthcare" 10 mg filmovertrukne tabletter
accord healthcare b.v. - montelukastnatrium - filmovertrukne tabletter - 10 mg
ramipril "2care4" 10 mg tabletter
2care4 aps - ramipril - tabletter - 10 mg
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
ezetrol 10 mg tabletter
2care4 aps - ezetimib - tabletter - 10 mg
sirdalud mr 6 mg depotkapsler, hårde
2care4 aps - tizanidinhydrochlorid - depotkapsler, hårde - 6 mg
zinnat 500 mg filmovertrukne tabletter
2care4 aps - cefuroximaxetil - filmovertrukne tabletter - 500 mg
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
atorvastatin "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 10 mg
atorvastatin "accord" 20 mg filmovertrukne tabletter
accord healthcare b.v. - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 20 mg
atorvastatin "accord" 40 mg filmovertrukne tabletter
accord healthcare b.v. - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 40 mg